GlassScriptPhysician profile
Adriana Herrera
NPI 1093080699
$1,035.53
in general payments reported to CMS, 2019-2025
13 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $127 · 2023: $385 · 2024: $124 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.33 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $360.82 | 2021-2024 | |
| Astellas Pharma US INC | $247.46 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $104.51 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $61.67 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $44.22 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $40.49 | 2022-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $33.63 | 2021-2022 | |
| Exeltis, USA INC. | $30.99 | 2023-2024 | Slynd |
| Myovant Sciences INC. | $30.02 | 2021-2022 | |
| Evofem Biosciences, INC. | $25.00 | 2024 | |
| Shield Therapeutics INC | $24.31 | 2024 | |
| Boston Scientific Corporation | $17.60 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.81 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adriana Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.